Leaders in Pharmaceutical Business Intelligence (LPBI) Group

• Commercialization of US Patents, Licensing or Sales Outright US Patents to Technology IP & Patents Funds

  Biologics, Small Molecules and Medical Devices US Patents

HQS – Boston, MA

HQS – Lausanne, Switzerland

• Inventors: Biologics
• Inventors: Medical Devices

OUR CURRENT PLAN FOR FUNDING GDE’s BUSINESS #4

• 4.1, 4.2, 4.3, 4.4 are under discussion with one of our Investment Houses (Paris)
• We need a similar Foundation to Melinda and Bill Gates that accept proposals for start ups in Biotech and Scientific Media for 4.5 and 4.6

4. Commercialization of US Patents

4.1 (Dr. Pearlman – Cardiovascular and other Medical Devices) – 12 Patents before met Aviva, two joint concepts after met Aviva, on PPA on 3D Printing of Stents coated by EPCs and NO (Aviva has prior art.)

4.2 (Bill Zurn – Cardiovascular and other Medical Devices) US Patents before and after met Aviva

Any Development of MEMS and 3D Printing is UNDER GDE’s M3DP

4.3 (Dr. Nir, SBH Sciences – Cytokines)

Any development of Hydrogel and Cytikines using 3D BioPrinting is UNDER GDE’s M3DP

4.4 (Dr. Briggs – Biologics – cancer galactic-3 and Liver Fibrosis) needs investment

4.5 NEW (Dr. Codrington, Cambridge, UK) – Diagnostics, Antibodies in Hematology) – Candidate for Foundation Funding or M&A with Diagnostics Leader

4.6 NEW (Dr. Evelyna Cohn, Richmond, VA) – BioChemical Coating of Protective Equipment against RNA Viruses Epidemic  – Candidate fof Foundations or Public Governmental Funding Sources